OrganiGram Financial Statements From 2010 to 2026

OGI Stock  USD 1.66  0.04  2.47%   
OrganiGram Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing OrganiGram Holdings' valuation are provided below:
Gross Profit
90.2 M
Profit Margin
(0.1)
Market Capitalization
223.2 M
Enterprise Value Revenue
1.0994
Revenue
259.2 M
We have found one hundred twenty available trending fundamental ratios for OrganiGram Holdings, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of OrganiGram Holdings recent fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The OrganiGram Holdings' current Market Cap is estimated to increase to about 340.2 M. The OrganiGram Holdings' current Enterprise Value is estimated to increase to about 269.5 M

OrganiGram Holdings Total Revenue

224.71 Million

Check OrganiGram Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OrganiGram Holdings' main balance sheet or income statement drivers, such as Interest Expense of 303.5 K, Selling General Administrative of 67.4 M or Other Operating Expenses of 301.3 M, as well as many indicators such as Price To Sales Ratio of 2.86, Dividend Yield of 0.0 or PTB Ratio of 0.82. OrganiGram financial statements analysis is a perfect complement when working with OrganiGram Holdings Valuation or Volatility modules.
  
Build AI portfolio with OrganiGram Stock
Check out the analysis of OrganiGram Holdings Correlation against competitors.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

OrganiGram Holdings Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets279.1 M464.2 M252.7 M
Slightly volatile
Total Current Liabilities152.3 M145.1 M39.8 M
Slightly volatile
Total Stockholder Equity217.1 M288.3 M192.3 M
Slightly volatile
Accounts Payable77.4 M73.7 M24.4 M
Slightly volatile
Cash36.6 M69 M33.6 M
Slightly volatile
Non Current Assets Total140.6 M229 M127 M
Slightly volatile
Cash And Short Term Investments63.3 M69.7 M55.3 M
Slightly volatile
Net Receivables56.2 M53.6 M19.1 M
Slightly volatile
Common Stock Shares Outstanding154.2 M146.8 M54.4 M
Slightly volatile
Liabilities And Stockholders Equity279.1 M464.2 M252.7 M
Slightly volatile
Other Stockholder Equity40.1 M38.2 M18.1 M
Slightly volatile
Total Liabilities184.7 M175.9 M67.6 M
Slightly volatile
Total Current Assets138.7 M235.2 M125.9 M
Slightly volatile
Property Plant And Equipment Net122.7 M141.4 M100.8 M
Slightly volatile
Common Stock Total Equity508 M483.8 M244.8 M
Slightly volatile
Non Current Liabilities Total105 M100 M39.7 M
Slightly volatile
Common Stock410.9 M759.6 M354.6 M
Slightly volatile
Inventory149.7 M142.5 M56.6 M
Slightly volatile
Short and Long Term Debt Total7.5 M7.9 M19.4 M
Very volatile
Net Tangible Assets258.4 M300.1 M189.3 M
Slightly volatile
Long Term Debt21.4 K22.5 K16.6 M
Very volatile
Long Term Debt Total35.1 M53 M31.9 M
Slightly volatile
Short and Long Term Debt27.3 K28.8 KM
Very volatile
Short Term Debt2.1 M1.2 M1.5 M
Pretty Stable
Property Plant Equipment150 M113.9 M101.6 M
Slightly volatile
Net Invested Capital385.7 M401.5 M259.9 M
Slightly volatile
Net Working Capital177.6 M182.5 M122.9 M
Slightly volatile
Capital Stock655.3 M1.1 B461.2 M
Slightly volatile

OrganiGram Holdings Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative67.4 M64.1 M25.5 M
Slightly volatile
Total Operating Expenses56.9 M80.8 M50.7 M
Slightly volatile
Depreciation And Amortization12.6 M14.8 M9.7 M
Slightly volatile
Selling And Marketing Expenses37.5 M35.8 M12.8 M
Slightly volatile
Total Revenue224.7 M214 M79.5 M
Slightly volatile
Interest Income12.4 M11.8 M6.3 M
Slightly volatile
Reconciled Depreciation16.2 M20.7 M10.4 M
Slightly volatile

OrganiGram Holdings Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow118.3 M112.7 M37.3 M
Slightly volatile
Capital Expenditures13.4 M14.1 M25 M
Pretty Stable
End Period Cash Flow36.6 M69 M33.6 M
Slightly volatile
Stock Based Compensation4.8 M4.8 M3.9 M
Slightly volatile
Depreciation13.1 M20.7 M10.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.863.00851.2628
Slightly volatile
PTB Ratio0.820.86344.0479
Slightly volatile
Days Sales Outstanding11311680.2788
Slightly volatile
Book Value Per Share6.916.57862.9514
Slightly volatile
Average PayablesM3.8 MM
Slightly volatile
Stock Based Compensation To Revenue0.03340.03520.0347
Pretty Stable
Capex To Depreciation1.861.95841.0114
Slightly volatile
PB Ratio0.820.86344.0479
Slightly volatile
EV To Sales2.432.56161.0072
Slightly volatile
Inventory Turnover0.911.67311.5227
Slightly volatile
Days Of Inventory On Hand186218235
Very volatile
Payables Turnover1.942.79564.1638
Very volatile
Sales General And Administrative To Revenue0.280.29430.3151
Slightly volatile
Average Inventory33.2 M31.6 M24.8 M
Slightly volatile
Research And Ddevelopement To Revenue0.03410.04090.0735
Slightly volatile
Capex To Revenue0.320.33450.1822
Pretty Stable
Cash Per Share1.021.28070.4911
Slightly volatile
Days Payables Outstanding137131102
Pretty Stable
Intangibles To Total Assets0.10.09740.0506
Slightly volatile
Current Ratio7.464.00876.0327
Pretty Stable
Tangible Book Value Per Share6.145.85042.7425
Slightly volatile
Receivables Turnover4.943.14434.7472
Slightly volatile
Shareholders Equity Per Share6.916.57862.9514
Slightly volatile
Debt To Equity0.00630.00660.0164
Slightly volatile
Capex Per Share0.60.63160.2612
Slightly volatile
Average Receivables1.2 M1.2 M1.1 M
Slightly volatile
Revenue Per Share1.021.8881.7927
Slightly volatile
Debt To Assets0.00550.00580.0143
Slightly volatile
Graham Number4.668.726.6125
Slightly volatile
Operating Cycle261334295
Slightly volatile
Price Book Value Ratio0.820.86344.0479
Slightly volatile
Days Of Payables Outstanding137131102
Pretty Stable
Ebt Per Ebit0.320.33330.336
Slightly volatile
Company Equity Multiplier1.81.13591.4664
Pretty Stable
Long Term Debt To Capitalization3.0E-44.0E-43.0E-4
Very volatile
Total Debt To Capitalization0.00620.00660.0161
Slightly volatile
Debt Equity Ratio0.00630.00660.0164
Slightly volatile
Net Income Per E B T0.70.99390.7033
Slightly volatile
Cash Ratio2.431.23932.322
Slightly volatile
Cash Conversion Cycle291204203
Slightly volatile
Days Of Inventory Outstanding186218235
Very volatile
Days Of Sales Outstanding11311680.2788
Slightly volatile
Price To Book Ratio0.820.86344.0479
Slightly volatile
Fixed Asset Turnover0.560.56121.4396
Slightly volatile
Debt Ratio0.00550.00580.0143
Slightly volatile
Price Sales Ratio2.863.00851.2628
Slightly volatile
Asset Turnover0.180.25270.4579
Slightly volatile
Gross Profit Margin0.210.21650.2245
Slightly volatile
Price Fair Value0.820.86344.0479
Slightly volatile

OrganiGram Holdings Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap340.2 M324 M197.8 M
Slightly volatile
Enterprise Value269.5 M256.7 M125.1 M
Slightly volatile

OrganiGram Fundamental Market Drivers

Forward Price Earnings114.9425
Cash And Short Term Investments60.6 M

OrganiGram Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
9th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
17th of December 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About OrganiGram Holdings Financial Statements

Investors use fundamental indicators, such as OrganiGram Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although OrganiGram Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue108.1 K113.5 K
Total Revenue214 M224.7 M
Cost Of Revenue206.2 M216.5 M
Stock Based Compensation To Revenue 0.04  0.03 
Sales General And Administrative To Revenue 0.29  0.28 
Research And Ddevelopement To Revenue 0.04  0.03 
Capex To Revenue 0.33  0.32 
Revenue Per Share 1.89  1.02 
Ebit Per Revenue(0.30)(0.31)

Currently Active Assets on Macroaxis

When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:
Check out the analysis of OrganiGram Holdings Correlation against competitors.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.14)
Revenue Per Share
2.03
Quarterly Revenue Growth
0.791
Return On Assets
(0.02)
Return On Equity
(0.07)
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.